Systemic fungal infections: A pharmacist/researcher perspective

Tackling the emerging threat of antifungal resistance to human health

(2022) Matthew C. Fisher et al.   NATURE REVIEWS MICROBIOLOGY

COVID-19-associated fungal infections in Iran: A systematic review

(2022) Tina Nazari et al.   PLoS One

COVID-19-associated fungal infections

(2022) Martin Hoenigl et al.   Nature Microbiology

COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease

(2021) Shivakumar Narayanan et al.   CLINICAL INFECTIOUS DISEASES

Collateral consequences of agricultural fungicides on pathogenic yeasts: A One Health perspective to tackle azole resistance

(2021) Débora Castelo‐Branco et al.   MYCOSES

107. A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules versus Fluconazole and Placebo in the Treatment of Acute Vulvovaginal Candidiasis Episodes in Subjects with Recurrent Vulvovaginal Candidiasis (ultraViolet)

(2021) Mark G Martens et al.   Open Forum Infectious Diseases

Coronavirus Disease 2019–Associated Invasive Fungal Infection

(2021) John W Baddley et al.   Open Forum Infectious Diseases

Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options

(2020) Laura Nunes Silva et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Antifungal use in the surgical ICU patient

(2019) Pedro Póvoa et al.   Current Opinion in Anesthesiology

Worldwide emergence of resistance to antifungal drugs challenges human health and food security

(2018) Matthew C. Fisher et al.   SCIENCE

An insight into new strategies to combat antifungal drug resistance

(2018) Yan-Hua Zheng et al.   Drug Design Development and Therapy

Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis

(2017) Radha Rajasingham et al.   LANCET INFECTIOUS DISEASES

2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis

(2016) John N. Galgiani et al.   CLINICAL INFECTIOUS DISEASES

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

(2016) Thomas F. Patterson et al.   CLINICAL INFECTIOUS DISEASES

Antifungal Agents

(2016) Jeniel E. Nett et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2015) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Genesis of Azole Antifungal Resistance from Agriculture to Clinical Settings

(2015) Maria-Manuel Azevedo et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Invasive Candidiasis

(2015) Bart Jan Kullberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

(2014) O.A. Cornely et al.   CLINICAL MICROBIOLOGY AND INFECTION

Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus

(2012) Eveline Snelders et al.   PLoS One

Hidden Killers: Human Fungal Infections

(2012) G. D. Brown et al.   Science Translational Medicine

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

(2010) John R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles

(2009) E. Snelders et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Invasive Trichosporonosis Caused byTrichosporon asahiiand Other UnusualTrichosporonSpecies at a Medical Center in Taiwan

(2009) Sheng‐Yuan Ruan et al.   CLINICAL INFECTIOUS DISEASES